ABFM KSA Behavioral Health revised
Leave the first rating
Save
Terms in this set (68) Hide definitions
,You are evaluating screening The question "Do you want help with this?"
instruments to help you better increases the sensitivity of a two-question anxiety
identify depression and anxiety in screen
your patients. Which one of the
following is NOT true regarding The Mood Disorder Questionnaire (MDQ) is a
screening instruments for mental validated self-administered tool that can be used
health disorders in primary care to screen for bipolar disorder. It correctly identifies
settings? almost three-quarters of patients with bipolar
disorder and will screen out bipolar disorder in 9 of
The Mood Disorder Questionnaire 10 patients without the condition. However, it is not
(MDQ) can be used to screen for a diagnostic instrument. Patients who screen
bipolar disorder positive must be further assessed before a formal
The PHQ-2 has high sensitivity for diagnosis is made or treatment is prescribed.The
depression sensitivity of the PHQ-2 for detecting depression in
The GAD-2 questionnaire can detect primary care settings is generally in the 70%-90%
several anxiety disorders range. The specificity, however, is generally in the
The GAD-7 can identify panic 60%-90% range.The GAD-2 has been shown to
disorder have a sensitivity and specificity in the 70%-90%
The question "Do you want help with range for generalized anxiety disorder, panic
this?" increases the sensitivity of a disorder, and social anxiety disorder, similar to the
two-question anxiety screen GAD-7. The sensitivity of the GAD-2 for detecting
posttraumatic stress disorder is in the 50%-60%
range, slightly lower than that of the GAD-7, but the
specificities of both are in the 80% range across
studies. The GAD-2 does not differentiate between
types of anxiety disorders.One study showed that
asking, "Do you want help with this today?"
increased the specificity of the PHQ-2 to 89%-98%
but did not increase the sensitivity. Asking this
question can also increase the specificity of the
GAD-2 from 77% to 99% but does not improve the
sensitivity.The PHQ-4 combines the two questions
from the PHQ-2 depression screen and the GAD-2
anxiety screen. Elevated scores have been shown
to relate to decreased patient functional status in
several mental and physical domains. The sensitivity
,and specificity of the PHQ-4 are both in the
70%-80% range, which is consistent with the
performance of its PHQ-2 and GAD-2
components.
, During a visit to establish care, a 60- Doxepin (Silenor) would be preferred to
year-old female requests a refill of temazepam for this condition
temazepam (Restoril), which she has
used for the past several months Insomnia accounts for more than five million visits
because of difficulty staying asleep. to family physicians each year. The DSM-5 criteria
Her sleep problem started when her for insomnia disorder include symptoms occurring
husband was being treated for 3 or more nights per week for 3 or more months
cancer. Other than well controlled that cause significant functional distress or
hypertension and occasional impairment. These symptoms should not be
symptoms from osteoarthritis in her associated with other disorders such as sleep
knees, she has no significant medical apnea. Only 6%-10% of persons have insomnia that
problems. She is not obese, does not meets these criteria, which is more common in
smoke, usually limits her alcohol women and in patients who are older, in poor
consumption to two glasses of wine general health, and/or have lower socioeconomic
on weekends, and has negative status.Cognitive-behavioral therapy and other
screening questionnaires for behavioral interventions such as sleep hygiene,
depression and anxiety. Her husband stimulus control, and relaxation are considered
has not mentioned that she has been first-line treatment for insomnia. The overall quality
snoring. of evidence for pharmacologic treatment is low,
but for those who fail to respond pharmacotherapy
Which one of the following is an option. Melatonin agonists such as ramelteon
statements is true regarding this can be used to accelerate sleep onset. The so-
scenario? called "z-drugs" (zolpidem, eszopiclone, and
Most patients with chronic sleep zaleplon) can be used for treating problems with
problems have primary insomnia sleep onset and sleep maintenance. Low-dose
Cognitive-behavioral therapy is doxepin can be used for those with difficulty
generally ineffective staying asleep, and doxepin and controlled-
Doxepin (Silenor) would be release melatonin are recommended as first-line
preferred to temazepam for this agents in older adults.There is insufficient evidence
condition to establish the comparative safety of one
Zolpidem (Ambien) is safe for long- pharmacologic treatment over another. The data
term on melatonin is mixed, and there is insufficient
evidence to make recommendations on trazodone
or diphenhydramine. The American College of
Physicians recommends that the choice to use
medications should be based on shared decision
making, and prescriptions should be limited to 5
Leave the first rating
Save
Terms in this set (68) Hide definitions
,You are evaluating screening The question "Do you want help with this?"
instruments to help you better increases the sensitivity of a two-question anxiety
identify depression and anxiety in screen
your patients. Which one of the
following is NOT true regarding The Mood Disorder Questionnaire (MDQ) is a
screening instruments for mental validated self-administered tool that can be used
health disorders in primary care to screen for bipolar disorder. It correctly identifies
settings? almost three-quarters of patients with bipolar
disorder and will screen out bipolar disorder in 9 of
The Mood Disorder Questionnaire 10 patients without the condition. However, it is not
(MDQ) can be used to screen for a diagnostic instrument. Patients who screen
bipolar disorder positive must be further assessed before a formal
The PHQ-2 has high sensitivity for diagnosis is made or treatment is prescribed.The
depression sensitivity of the PHQ-2 for detecting depression in
The GAD-2 questionnaire can detect primary care settings is generally in the 70%-90%
several anxiety disorders range. The specificity, however, is generally in the
The GAD-7 can identify panic 60%-90% range.The GAD-2 has been shown to
disorder have a sensitivity and specificity in the 70%-90%
The question "Do you want help with range for generalized anxiety disorder, panic
this?" increases the sensitivity of a disorder, and social anxiety disorder, similar to the
two-question anxiety screen GAD-7. The sensitivity of the GAD-2 for detecting
posttraumatic stress disorder is in the 50%-60%
range, slightly lower than that of the GAD-7, but the
specificities of both are in the 80% range across
studies. The GAD-2 does not differentiate between
types of anxiety disorders.One study showed that
asking, "Do you want help with this today?"
increased the specificity of the PHQ-2 to 89%-98%
but did not increase the sensitivity. Asking this
question can also increase the specificity of the
GAD-2 from 77% to 99% but does not improve the
sensitivity.The PHQ-4 combines the two questions
from the PHQ-2 depression screen and the GAD-2
anxiety screen. Elevated scores have been shown
to relate to decreased patient functional status in
several mental and physical domains. The sensitivity
,and specificity of the PHQ-4 are both in the
70%-80% range, which is consistent with the
performance of its PHQ-2 and GAD-2
components.
, During a visit to establish care, a 60- Doxepin (Silenor) would be preferred to
year-old female requests a refill of temazepam for this condition
temazepam (Restoril), which she has
used for the past several months Insomnia accounts for more than five million visits
because of difficulty staying asleep. to family physicians each year. The DSM-5 criteria
Her sleep problem started when her for insomnia disorder include symptoms occurring
husband was being treated for 3 or more nights per week for 3 or more months
cancer. Other than well controlled that cause significant functional distress or
hypertension and occasional impairment. These symptoms should not be
symptoms from osteoarthritis in her associated with other disorders such as sleep
knees, she has no significant medical apnea. Only 6%-10% of persons have insomnia that
problems. She is not obese, does not meets these criteria, which is more common in
smoke, usually limits her alcohol women and in patients who are older, in poor
consumption to two glasses of wine general health, and/or have lower socioeconomic
on weekends, and has negative status.Cognitive-behavioral therapy and other
screening questionnaires for behavioral interventions such as sleep hygiene,
depression and anxiety. Her husband stimulus control, and relaxation are considered
has not mentioned that she has been first-line treatment for insomnia. The overall quality
snoring. of evidence for pharmacologic treatment is low,
but for those who fail to respond pharmacotherapy
Which one of the following is an option. Melatonin agonists such as ramelteon
statements is true regarding this can be used to accelerate sleep onset. The so-
scenario? called "z-drugs" (zolpidem, eszopiclone, and
Most patients with chronic sleep zaleplon) can be used for treating problems with
problems have primary insomnia sleep onset and sleep maintenance. Low-dose
Cognitive-behavioral therapy is doxepin can be used for those with difficulty
generally ineffective staying asleep, and doxepin and controlled-
Doxepin (Silenor) would be release melatonin are recommended as first-line
preferred to temazepam for this agents in older adults.There is insufficient evidence
condition to establish the comparative safety of one
Zolpidem (Ambien) is safe for long- pharmacologic treatment over another. The data
term on melatonin is mixed, and there is insufficient
evidence to make recommendations on trazodone
or diphenhydramine. The American College of
Physicians recommends that the choice to use
medications should be based on shared decision
making, and prescriptions should be limited to 5
